New drug filgotinib shows promise for arthritis relief in korean study
Disease control
Completed
This study tested the drug filgotinib in 118 Korean adults with rheumatoid arthritis to see if it improves symptoms and controls disease activity. Participants took the drug for up to 24 weeks, and doctors measured joint pain, swelling, and inflammation. The goal was to see how m…
Phase: PHASE4 • Sponsor: Eisai Korea Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC